Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Docosahexaenoic acid (DHA, C22:6) is highly enriched in brain, synapses, and retina and is a major omega-3 fatty acid. Deficiencies in this essential fatty acid are reportedly associated with neuronal function, cancer, and inflammation. Here, using new lipidomic analyses employing high performance liquid chromatography coupled with a photodiode-array detector and a tandem mass spectrometer, a novel series of endogenous mediators was identified in blood, leukocytes, brain, and glial cells as 17S-hydroxy-containing docosanoids denoted as docosatrienes (the main bioactive member of the series was 10,17S-docosatriene) and 17S series resolvins. These novel mediators were biosynthesized via epoxide-containing intermediates and proved potent (pico- to nanomolar range) regulators of both leukocytes reducing infiltration in vivo and glial cells blocking their cytokine production. These results indicate that DHA is the precursor to potent protective mediators generated via enzymatic oxygenations to novel docosatrienes and 17S series resolvins that each regulate events of interest in inflammation and resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![FIG. 3 Human glial cells release and transform DHA. A , human glial cells were labeled with [1- 14 C]DHA and exposed to either PBS alone, zymosan A, or calcium ionophore (see 'Experimental Procedures'). Released [114 C]docosanoids were quantified ( n = 4). The asterisk denotes significant differences from control (PBS alone), p < 0.05 analysis of variance, Newman-Keuls test. The inset shows a representative HPLC radiochromatogram of released [1- 14 C]docosanoids (see 'Experimental Procedures') from glial cells exposed to zymosan A ( n = 3). Phospholipids from glial cells were identified, and the 14 C content in phosphatidylethanolamine ( PE ) was determined. The percent loss in PE 14 C content from cells exposed to agonists was determined ( n = 2). B , lipidomic profile of human glial cells exposed to Ca 2 + ionophore: LC-MS total ion chromatogram of released products. C , LC-MS selective ion chromatogram of released DHA-derived products from glial cells exposed to calcium ionophore. MS-MS and UV spectra of 𝛚 -22hydroxy-4 S ,17 S -diHDHA.](https://figures.cochat.ai/paper-figures/3022e35eb41542a6a28d8ac7db63b15b/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-3.png)



![FIG. 5 Substrate competition at human recombinant COX-2. Human rCOX-2 microsomal membranes from Sf9 cells were incubated with [1- 14 C]DHA (C22:6, 10 𝛍 M) in the presence of increasing concentrations of unlabeled arachidonic acid (C20:4). COX-2 conversion of [1- 14 C]DHA and specific product profiles were quantitated ( n = 3). rCOX-2 activity is expressed as the inhibition of [ 14 C]C22:6 product formation (95 ± 0.5%; conversion of DHA was set to 100%).](https://figures.cochat.ai/paper-figures/b879709650c441a69692ab58e3270712/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-5.png)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationMarchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationA NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
Burr, G. O., & Burr, M. M. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78281-5 · Cited by 1,185
Gunstone, F. D., Harwood, J. L., & Padley, F. B. (1994) · Cited by 1,010
Mechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Research works printed but not linked: 8
- Gallin, J. I., and Snyderman, R. (eds) (1999) Inflammation: Basic Principles and Clinical Correlates, Lippincott Williams & Wilkins, Philadelphia
- Bergstro ¨m, S. (1982) in Les Prix Nobel: Nobel Prizes, Presentations, Biogra- phies and Lectures, pp. 129 -148, Almqvist & Wiksell, Stockholm
- De Caterina, R., Endres, S., Kristensen, S. D., and Schmidt, E. B. (eds) (1993) n-3 Fatty Acids and Vascular Disease, Springer-Verlag, London
- Gronert, K., Clish, C. B., Romano, M., and Serhan, C. N. (1999) in Eicosanoid Protocols (Lianos, E. A., ed) pp. 119 -144, Humana Press, Totowa, NJ 28.
- Gronert, K., Colgan, S. P., and Serhan, C. N. (1998) J. Pharmacol. Exp. Ther. 285, 252-261
- Whelan, J., Reddanna, P., Nikolaev, V., Hildenbrandt, G. R., and Reddy, T. S. (1990) in Biological Oxidation Systems Vol. 2, pp. 765-778, Academic Press
- Bazan, N. G. (1990) in Nutrition and the Brain (Wurtman, R. J., and Wurtman, J. J., eds) Vol. 8, pp. 1-22, Raven Press, New York
- Bazan, N. G., and Rodriguez de Turco, E. B. (2001) in Neuroprotection (Lo, E. H., and Marwoh, J., eds) pp. 195, Prominent Press
Cited by
Items 401–500 of 997
Tonic inhibition of chemotaxis in human plasma
Malawista, S. E., de Boisfleury Chevance, A., van Damme, J., & Serhan, C. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802572105 · Cited by 54
Self-citationYin, H., Brooks, J. D., Gao, L., Porter, N. A., & Morrow, J. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703108200 · Cited by 66
Long Chain n-3 Polyunsaturated Fatty Acids in the Prevention of Allergic and Cardiovascular Disease
van den Elsen, L. W. J., Garssen, J., & Willemsen, L. E. M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165960 · Cited by 57
Luo, B., Han, F., Xu, K. W., Wang, J., Liu, Z., Shen, Z., Li, J., Liu, Y., Jiang, M., Zhang, Z., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0020-16.2016 · Cited by 57
“RvD1 can regulate the migration of neutrophils and enhances the macrophage phagocytosis of apoptotic leukocytes in an ALX/FPR2-dependent manner, which contributes to the resolution of inflammation (Hong et al., 2003; Sun et al., 2007; Spite et al., 2009; Krishnamoorthy et al., 2010).”
BackgroundTerrone, G., Pauletti, A., Salamone, A., Rizzi, M., Villa, B. R., Porcu, L., Sheehan, M. J., Guilmette, E. R., Butler, C. R., Piro, J. R., et al. (2017) · Epilepsia · doi:10.1111/epi.13950 · Cited by 55
“The diet’s antiinflammatory effect can be mediated by dietary polyunsaturated fatty acids (PUFAs): in particular, N-3 PUFAs decrease the production of inflammatory eicosanoids, cytokines, and reactive oxygen species by inhibiting the nuclear factor kappa B (NF-jB)–mediated transcriptional activation of inflammatory ge…”
BackgroundBioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration
Wasserman, A. H., Venkatesan, M., & Aguirre, A. (2020) · Cells · doi:10.3390/cells9061391 · Cited by 50
Taha, A. Y., Filo, E., David, W. L., & Burnham, W. M. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01731.x · Cited by 55
Winkler, J. W., Uddin, J., Serhan, C. N., & Petasis, N. A. (2013) · Organic Letters · doi:10.1021/ol400484u · Cited by 55
Self-citationHong, S., Tian, H., Lu, Y., Laborde, J. M., Muhale, F. A., Wang, Q., Alapure, B. V., Serhan, C. N., & Bazan, N. G. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00270.2014 · Cited by 53
Self-citationAursnes, M., Tungen, J. E., Vik, A., Dalli, J., & Hansen, T. V. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41902a · Cited by 54
Rogalski, M., & Carrer, H. (2011) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2011.00621.x · Cited by 57
“VLCPUFAs containing at least 20 carbons such as x-3 EPA and DHA are valuable commodities that provide important human health benefits in various physiological and pathophysiological processes (Spector, 1999; Funk, 2001; Hong et al., 2003).”
BackgroundBiosynthesis of proresolving lipid mediators by vascular cells and tissues
Chatterjee, A., Komshian, S. R., Sansbury, B. E., Wu, B., Mottola, G., Chen, M., Spite, M. R., & Conte, M. S. (2017) · The FASEB Journal · doi:10.1096/fj.201700082r · Cited by 54
“For instance, 15-LOX facilitates the conversion of DHA to a 17S-hydroperoxide intermediate that is the precursor to D-series resolvins and protectins (4).”
BackgroundHinz, C., Liggi, S., Mocciaro, G., Jung, S. M., Induruwa, I., Pereira, M. C. A., Bryant, C. E., Meckelmann, S. W., O’Donnell, V. B., Farndale, R. W., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04615 · Cited by 53
Focused metabolomic profiling in the drug development process: advances from lipid profiling
Morris, M. S., & Watkins, S. M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.06.002 · Cited by 60
Highly-parallel metabolomics approaches using LC-MS2 for pharmaceutical and environmental analysis
Bajad, S. U., & Shulaev, V. (2007) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2007.02.009 · Cited by 53
Bazinet, R. P., Rao, J. S., Chang, L., Rapoport, S. I., & Lee, H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0059-7 · Cited by 59
Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome
Shinohara, M., Mirakaj, V., & Serhan, C. N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00081 · Cited by 52
“Earlier results indicated that NPD1/PD1 exerted potent antiinflammatory actions regulating leukocyte trafficking in murine systems (Serhan et al., 2002; Hong et al., 2003).”
ResultSelf-citationBasselin, M., Kim, H.-W., Chen, M., Ma, K., Rapoport, S. I., Murphy, R. C., & Farias, S. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002469 · Cited by 52
RetractedAtherosclerosis is a major human killer and non-resolving inflammation is a prime suspect
Fredman, G., & MacNamara, K. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab309 · Cited by 64
Resolvin D1 and its GPCRs in resolution circuits of inflammation
Recchiuti, A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.02.004 · Cited by 59
Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
Das, U. N. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00182 · Cited by 57
Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: Role of PPAR-α and SREBP-1c
Dossi, C. G., Tapia, G. S., Espinosa, A., Videla, L. A., & D'Espessailles, A. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.04.011 · Cited by 51
Knöchel, C., Voß, M., Grüter, F., Alves, G. S., Matura, S., Sepanski, B., Stäblein, M., Wenzler, S., Prvulovic, D., Carvalho, A. F., et al. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630173047 · Cited by 57
“Resolvins, docosatriens and neuroprotectins metabolised from DHA are also of anti-inflammatory action [53, 54], but may have additional neuroprotective mechanisms [55-57].”
BackgroundPerry, S., Kalyanaraman, C., Tourdot, B. E., Conrad, W. S., Akinkugbe, O., Freedman, J. C., Holinstat, M. A., Jacobson, M. P., & Holman, T. R. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000777 · Cited by 56
“Previously, 7S,17S-diDHA (RvD5) was proposed to be biosynthesized from DHA in two steps: initial oxygenation of C7 by h5-LOX followed by oxygenation of C17 by h15-LOX-1 (27, 28).”
BackgroundInfluentialSerhan, C. N., & Chiang, N. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106718 · Cited by 59
Self-citationLipid Mediators in Cerebral Spinal Fluid of Traumatic Brain Injured Patients
Farias, S., Heidenreich, K. A., Wohlauer, M. V., Murphy, R. C., & Moore, E. E. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182092c62 · Cited by 51
Hong, S., Lu, Y., Tian, H., Alapure, B. V., Wang, Q., Bunnell, B. A., & Laborde, J. M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.06.010 · Cited by 50
Self-citationO’Flaherty, J. T., Hu, Y., Wooten, R. E., Horita, D. A., Samuel, M. P., Thomas, M. J., Sun, H., & Edwards, I. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045480 · Cited by 58
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Ritsner, M. S. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5 · Cited by 51
Hansen, T. V., Dalli, J., & Serhan, C. N. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.06.003 · Cited by 52
“Previously it has been reported that ALOX-15 enables the formation of 17(S)-HpDHA in human whole blood, human leukocytes, human glial cells, and mouse brain [16].”
Self-citationBazan, N. G. (2007) · Springer eBooks · doi:10.1007/0-387-32442-9_74 · Cited by 55
“NPD1 synthesized by ARPE-19 cells is the same as that of the docosatriene found in human blood, glial cells, mouse brain ( Hong et al., 2003 ), and during brain ischemia-reperfusion (Marcheselli et al., 2003).”
BackgroundColombelli, C., Aoun, M., & Tiranti, V. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9770-z · Cited by 57
Thermally Activated TRPV3 Channels
Luo, J., & Hu, H. (2014) · Current topics in membranes · doi:10.1016/b978-0-12-800181-3.00012-9 · Cited by 56
Lipoxins as biomarkers of lupus and other inflammatory conditions
Das, U. N. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-76 · Cited by 52
Burks, W., Jones, S. M., Berseth, C. L., Harris, C. L., Sampson, H. A., & Scalabrin, D. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.02.043 · Cited by 49
Taha, A. Y., Blanchard, H. C., Cheon, Y., Ramadan, E., Chen, M., Chang, L., & Rapoport, S. I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9968-1 · Cited by 54
Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol
Carlson, S. E., Gajewski, B. J., Valentine, C. J., Rogers, L. K., Weiner, C. P., DeFranco, E., & Buhimschi, C. S. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1244-5 · Cited by 52
Tang, R., Lin, Y.-M., Liu, H.-X., & Wang, E.-S. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.03.017 · Cited by 49
Role of metabolic programming in the modulation of microglia phagocytosis by lipids
Nadjar, A. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.07.006 · Cited by 49
Crouch, M. J., Kosaraju, R., Guesdon, W., Armstrong, M., Reisdorph, N. A., Jain, R., Fenton, J. I., & Shaikh, S. R. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi1017-405rr · Cited by 53
Darwesh, A. M., Sosnowski, D. K., Lee, T. Y., Keshavarz-Bahaghighat, H., & Seubert, J. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.04.037 · Cited by 56
Do polyunsaturated fatty acids protect against bone loss in our aging and osteoporotic population?
Martyniak, K., Wei, F., Ballesteros, A., Meckmongkol, T. T., Calder, A. N., Gilbertson, T. A., Orlovskaya, N. A., & Coathup, M. J. (2020) · Bone · doi:10.1016/j.bone.2020.115736 · Cited by 57
Mediator Lipidomics: Search Algorithms for Eicosanoids, Resolvins, and Protectins
Serhan, C. N., Lu, Y., Hong, S., & Yang, R. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)32012-0 · Cited by 53
Self-citationChêne, G., Dubourdeau, M., Balard, P., Escoubet‐Lozach, L., Orfila, C., Berry, A., Bernad, J., Ariès, M.-F., Charvéron, M., & Pipy, B. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.014 · Cited by 58
Pro-resolving actions of SPM in adipose tissue biology
Clària, J., López‐Vicario, C., Rius, B., & Titos, E. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.004 · Cited by 52
Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation
Peh, H. Y., & Chen, J. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108753 · Cited by 56
Aukema, H., Winter, T., Ravandi, A., Dalvi, S., Miller, D. W., & Hatch, G. (2016) · Lipids · doi:10.1007/s11745-015-4074-0 · Cited by 43
Bioactive lipids as new class of microglial modulators: When nutrition meets neuroimunology
Nadjar, A., Leyrolle, Q., Joffre, C., & Layé, S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.004 · Cited by 51
“, 2000), and D-series resolvins (RvDs), protectin/neuroprotectin (PD/NPD), and maresins (MaRs) derived from DHA (Hong et al., 2003; Serhan et al., 2002).”
Sparvero, L. J., Amoscato, A. A., Fink, A. B., Anthonymuthu, T. S., New, L. A., Kochanek, P. M., Watkins, S. C., Kagan, V. E., & Bayır, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13840 · Cited by 50
“On the other hand, DHA is converted into resolvins and neuroprotectins via 15-LOX-like enzymes (Hong et al. 2003; Marcheselli et al. 2003).”
Niazi, Z. R., da Silva, G. C., Ribeiro, T. P., León‐González, A. J., Kassem, M., Mirajkar, A., Alvi, A. Z., Abbas, M., Zgheel, F., Schini‐Kerth, V. B., et al. (2017) · Hypertension Research · doi:10.1038/hr.2017.72 · Cited by 54
Lee, C. H. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01299-y · Cited by 51
“Like other members of PUFA metabolites specialized pro-resolving mediators class, PD1 exerts potent anti-inflammatory and anti-apoptotic/neuroprotective biological activities (Hong et al. 2003; Bazan 2007).”
BackgroundMurphy, E. J. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.07.005 · Cited by 50
Endogenous Receptor Agonists: Resolving Inflammation
Bannenberg, G., Arita, M., & Serhan, C. N. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.188 · Cited by 47
“Both 17Shydroxy-DHA and NPD1 have been shown to potently reduce TNF-α-stimulated IL-1β gene transcription in human glial cells[152].”
BackgroundInfluentialSelf-citationLiu, X., Moon, S. H., Mancuso, D. J., Jenkins, C. M., Guan, S., Sims, H. F., & Gross, R. W. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.06.014 · Cited by 47
Vemuri, M., Kelley, D. S., Mackey, B. E., Rasooly, R., & Bartolini, G. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0007 · Cited by 46
Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation
Titos, E., & Clària, J. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.05.003 · Cited by 57
Dihydroxylated E,E,Z-docosatrienes. An overview of their synthesis and biological significance
Balas, L., & Durand, T. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.10.002 · Cited by 48
First total synthesis of 7(S),17(S)-Resolvin D5, a potent anti-inflammatory docosanoid
Rodríguez, A. R., & Spur, B. W. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.03.175 · Cited by 47
Prevention and treatment of cancers by immune modulating nutrients
Janakiram, N. B., Mohammed, A., Madka, V., Kumar, G., & Rao, C. V. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500884 · Cited by 52
“Increased resolvins were produced by fish oil diets, and increased resolvin production was observed in colitis-induced Fat1 mice [197,198].”
Resolvins as Regulators of the Immune System
Seki, H., Sasaki, T., Ueda, T., & Arita, M. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.72 · Cited by 53
Targeted chiral lipidomics analysis
Lee, S. H., Williams, M. V., & Blair, I. A. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.01.009 · Cited by 50
Petasis, N. A., Yang, R., Winkler, J. W., Zhu, M., Uddin, J., Bazan, N. G., & Serhan, C. N. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.01.032 · Cited by 45
Self-citationSynaptic Signaling by Lipids in the Life and Death of Neurons
Bazan, N. G. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:219 · Cited by 50
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice
Yatomi, M., Hisada, T., Ishizuka, T., Koga, Y., Ono, A., Kamide, Y., Seki, K., Aoki‐Saito, H., Tsurumaki, H., Sunaga, N., et al. (2015) · Physiological Reports · doi:10.14814/phy2.12628 · Cited by 50
“Resolvin D1 (RvD1) is a member of the resolvin family of lipid mediators that are derived from docosahexaenoic acid (DHA), an x-3 fatty acid (Serhan et al. 2000, 2002; Hong et al. 2003).”
BackgroundTowards a whole-body systems [multi-organ] lipidomics in Alzheimer’s disease
Astarita, G., & Piomelli, D. (2011) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2011.04.021 · Cited by 44
Lipid-Based Therapy for Ocular Surface Inflammation and Disease
Lim, A. Y.-L., Wenk, M. R., & Tong, L. H. T. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.10.001 · Cited by 50
Shalini, S.-M., Ho, C. F., Ng, Y., Tong, J. X., Ong, E. S., Herr, D. R., Dawe, G. S., & Ong, W. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0413-x · Cited by 45
“They can modulate the effects of proinflammatory eicosanoids derived from AA [11], reduce leukocyte trafficking, and downregulate cytokine expression [11].”
BackgroundPerivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model
Wu, B., Werlin, E. C., Chen, M., Mottola, G., Chatterjee, A., Lance, K. D., Bernards, D. A., Sansbury, B. E., Spite, M. R., Desai, T. A., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.05.206 · Cited by 44
Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways
Mowry, F. E., & Biancardi, V. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.029 · Cited by 49
Igarashi, M., Kim, H., Chang, L., Ma, K., & Rapoport, S. I. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07597.x · Cited by 44
“DHA can be lost from brain by b-oxidation, by conversion to bioactive docosanoids such as resolvins, docosatrienes, and neuroprotectins by enzymes such as 15-LOX, and by other metabolic pathways (Gavino and Gavino 1991; Robinson et al. 1992; Hong et al. 2003; Gleissman et al. 2010; Arnold et al. 2010; Bazan et al. 201…”
InfluentialFlorent‐Béchard, S., Malaplate, C., Koziel, V., Kriem, B., Olivier, J. L., Pillot, T., & Oster, T. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.046 · Cited by 54
Next-generation biomaterials for dental pulp tissue immunomodulation
Dal‐Fabbro, R., Swanson, W. B., Capalbo, L. C., Sasaki, H., & Bottino, M. C. (2023) · Dental Materials · doi:10.1016/j.dental.2023.03.013 · Cited by 54
Tungen, J. E., Aursnes, M., Vik, A., Ramon, S., Colas, R. A., Dalli, J., Serhan, C. N., & Hansen, T. V. (2014) · Journal of Natural Products · doi:10.1021/np500498j · Cited by 46
Self-citationBasselin, M., Ramadan, E., & Rapoport, S. I. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.12.001 · Cited by 43
“In addition, chronic lithium treatment of the rats increased brain levels of a 17-hydroxy-DHA (Basselin et al., 2010a), a DHA metabolite that is a precursor of anti-inflammatory compounds known as docosanoids (Hong et al., 2003; Serhan, 2006).”
BackgroundLipid-Mediated Cell Signaling Protects against Injury and Neurodegeneration
Zhang, C., & Bazan, N. G. (2010) · Journal of Nutrition · doi:10.3945/jn.109.114884 · Cited by 46
Omega-3 fatty acids as an adjunct for periodontal therapy—a review
Chee, B., Park, B., Fitzsimmons, T. R., Coates, A. M., & Bartold, P. M. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1750-2 · Cited by 54
Redox (phospho)lipidomics of signaling in inflammation and programmed cell death
Tyurina, Y. Y., Croix, C. M. S., Watkins, S. C., Watson, A. M., Epperly, M. W., Anthonymuthu, T. S., Kisin, E. R., Vlasova, I. I., Krysko, O., Krysko, D. V., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0119-004rr · Cited by 49
Sacha inchi oil encapsulation: Emulsion and alginate beads characterization
Silva, K. F. C. E., Carvalho, A. G. D. S., Rabelo, R. S., & Hubinger, M. D. (2019) · Food and Bioproducts Processing · doi:10.1016/j.fbp.2019.05.001 · Cited by 44
Farina, E. K., Kiel, D. P., Roubenoff, R., Schaefer, E. J., Cupples, L. A., & Tucker, K. L. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1581 · Cited by 48
“We also were not able to adjust for use of nonsteroidal anti-inflammatory drugs, such as aspirin, which may be involved in generating the production of pro-resolving lipid mediators, lipoxins and resolvins.((11,63))”
BackgroundRecent advances in targeting COX-2 for cancer therapy: a review
Kassab, A. E. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00196j · Cited by 51
Aursnes, M., Tungen, J. E., Colas, R. A., Vlasakov, I., Dalli, J., Serhan, C. N., & Hansen, T. V. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00574 · Cited by 47
Self-citationResolvins as proresolving inflammatory mediators in cardiovascular disease
Capó, X., Martorell, M., Busquets-Cortés, C., Tejada, S., Tur, J. A., Pons, A., & Sureda, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.018 · Cited by 47
Diet and medical foods in Parkinson’s disease
Lange, K. W., NAKAMURA, Y., Chen, N., Guo, J., Kanaya, S., Lange, K. M., & Li, S. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.03.006 · Cited by 51
Wildburger, N. C., Wood, P. L., Gumin, J., Lichti, C. F., Emmett, M. R., Lang, F. F., & Nilsson, C. L. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00076 · Cited by 44
Fiala, M., Terrando, N., & Dalli, J. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150367 · Cited by 41
Serini, S., Vasconcelos, R. O., Fasano, E., & Calviello, G. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1139085 · Cited by 43
“as lipoxines or resolvins and protectins, described below).[50,51] Also, AA-derived PGD2 may elicit proresolving action by binding to its receptor DP1 or by being converted nonenzymatically to its bioactive derivative belonging to the J2 series.”
BackgroundChitosan porous 3D scaffolds embedded with resolvin D1 to improve in vivo bone healing
Vasconcelos, D. P., Costa, M. M., Nevès, N., Teixeira, J. H., Vasconcelos, D. M., Santos, S. G., Águas, A. P., Barbosa, M. A., & Barbosa, J. N. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36370 · Cited by 47
Durán, A. M., Salto, L., Camara, J. R., Basu, A., Perez‐Paquien, I., Beeson, W. L., Firek, A. F., Cordero‐MacIntyre, Z., & León, M. A. D. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s187268 · Cited by 46
Veyrat‐Durebex, C., Bris, C., Codron, P., Bocca, C., Chupin, S., Corcia, P., Vourc’h, P., Hergesheimer, R. C., Cassereau, J., Funalot, B., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1484-7 · Cited by 45
Karp, C. L., Flick, L. M., Yang, R., Uddin, J., & Petasis, N. A. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.015 · Cited by 41
The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice
Su, P. P., Zhang, L., He, L., Zhao, N., & Guan, Z. (2022) · Journal of Pain Research · doi:10.2147/jpr.s246883 · Cited by 47
Alfonso Valenzuela, B. (2009) · Grasas y Aceites · doi:10.3989/gya.085208 · Cited by 54
“Several mechanisms could explain these deficits, including an increased activity of phospholipase A2 thus inducing the extraction of AA and DHA from cerebral membranes (Horrobin et al., 1994).”
BackgroundFinkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 44
Targeting Angiogenesis via Resolution of Inflammation
Kelly, A. G., & Panigrahy, D. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041172 · Cited by 48
Rasquel-Oliveira, F. S., da Silva, M. D. V., Martelossi-Cebinelli, G., Fattori, V., Casagrande, R., & Verri, W. A., Jr. (2023) · Molecules · doi:10.3390/molecules28135032 · Cited by 49
“There are also aspirin-triggered (AT) RvDs, such as AT-RvD1 and AT-RvD2—the difference in biosynthesis is in the initial lipoxygenation of C-17, which occurs in the presence of aspirin through acetylated COX-2 or via cytochrome P450 [25].”
BackgroundInfluentialOgundipe, E., Tusor, N., Wang, Y., Johnson, M. R., Edwards, A. D., & Crawford, M. A. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.09.001 · Cited by 38
de Gaetano, M., McEvoy, C. M., Andrews, D. C., Cacace, A., Hunter, J., Brennan, E. P., & Godson, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01488 · Cited by 45
Ghaffari-Makhmalbaf, P., Sayyad, M., Pakravan, K., Razmara, E., Bitaraf, A., Bakhshinejad, B., Goudarzi, P., Yousefi, H., Pournaghshband, M., Nemati, F., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118719 · Cited by 40
Walker, K. H., Krishnamoorthy, N., Brüggemann, T. R., Shay, A. E., Serhan, C. N., & Levy, B. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.704427 · Cited by 42
Self-citation
Metadata
- Authors
- Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 278
- Issue
- 17
- Pages
- 14677-14687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082649626
- Cited by
- 1,000
- References
- 53
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 24 · 2021: 42 · 2020: 36 · 2019: 51 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 59 · 2014: 66 · 2013: 63 · 2012: 48
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6388 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK60583, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- docosahexaenoic acid, docosanoids, omega-3 fatty acids, leukocyte infiltration, glial cells, cytokine production, inflammation resolution, epoxide intermediate, lipidomics, brain, leukocytes, leukotriene biosynthesis
- MeSH terms
- Animals, Blood, Brain, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Humans, Inflammation, Leukocytes, Neuroglia, Mass Spectrometry, Tumor Necrosis Factor-alpha, Cytokines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.